Thermo Fisher Scientific to acquire point-of-care molecular diagnostics provider Mesa Biotech
The acquisition aims to meet continuing demand for COVID-related testing as well as develop point-of care tests for future infectious diseases
The acquisition aims to meet continuing demand for COVID-related testing as well as develop point-of care tests for future infectious diseases
The collaboration aims to advance the scale-up of hMSC manufacturing for regenerative medicine
Proposed transaction builds on both companies’ strategic R&D partnership
Cabenuva allows virologically suppressed adults with HIV to maintain viral suppression with 12 dosing days per year
Developed in partnership with Rosetta Biosciences, discovery enables simultaneous detection of multiple targets, furthering next generation of diagnostics
Video explains the top 5 reasons why to switch from manual to automatic titration
QIAstat-Dx and NeuMoDx tests continue to detect all known viral variants extremely effectively
The strategic collaboration aims to accelerate clinical trials and drive critical developments for promising COVID-19 treatments
The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years
The new institute aims to meet the urgent need to do more research into the antimicrobial resistance
In this article, Thurid Gspann, chairwoman of the Graphene Flagship Standardization Committee (GFSC), explains why standardization is important
This system aims to combine Shimadzu gas chromatography with the patented technology jointly owned by TOTAL, UPPA, and UO
This aims to improve hygiene in public transportation and a reduction in transmission of infections of various origins